GeoVax Labs, Inc. (GOVX)
Nasdaq: GOVX · Pharmaceutical Preparations · Smyrna, GA · filing with the SEC since 1996
Who runs GeoVax Labs, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Dodd David A
President, CEO. First filing Mar 2010, latest Jun 22, 2026, 6 filings in all.
Officers reporting now
6
of 11 people with a filing in the last fifteen months
Directors reporting now
5
13 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Dodd David A | President, CEO | Mar 2010 | Jun 22, 2026 | none |
| Mcnally Robert T | President/CEO | Dec 2006 | Jun 22, 2026 | none |
| Reynolds Mark | CFO | Oct 2006 | Jun 22, 2026 | none |
| Mckee Kelly T. Jr. | Chief Medical Officer | Jan 2022 | Jun 22, 2026 | none |
| Newman Mark J | Chief Scientific Officer | Jan 2010 | Jun 22, 2026 | none |
| Sharkey John W. | VP, Business Development | Jun 2022 | Jun 22, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chase Randal D | director | Mar 2015 | Jun 22, 2026 | none |
| Kollintzas Dean G | director | Oct 2006 | Jun 22, 2026 | none |
| Lemerond Nicole | director | Sep 2022 | Jun 22, 2026 | none |
| Morgan Jayne | director | Dec 2022 | Jun 22, 2026 | none |
| Spencer John N Jr | director | Oct 2006 | Jun 22, 2026 | none |
Earlier names on the record2, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.